Company: ZCARW
Filing Date: 2025-05-12
Form Type: S-1/A
Source: 0001213900-25-041769
Chunk: 230

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-05-12
Form: S-1/A
Chunk 230
---

 the Board of Directors, beneficially owns 82,282 shares of Common Stock,                                                             |

145 DILUTION If you invest in our securities in this offering, your ownership interest will be diluted immediately to the extent of the difference between the public offering price per share and the pro forma, as adjusted net tangible book value per share of Common Stock immediately after this offering. Dilution in net tangible book value per share represents the difference between the amount per share paid by purchasers in this offering and the net tangible book value per share of our shares of Common Stock immediately after this offering. Our net tangible book value is determined by dividing our total tangible assets, less total liabilities, by the number of our shares of Common Stock outstanding as of December 31, 2024. Our net tangible book value as of December 31, 2024, was $(38,430,212), or $(113.39) per share of Common Stock. On a pro forma basis, giving effect to (a) the closing of the January/February Offering which was closed on February 4, 2025, for the issuance of an aggregate of (i) 52,490 shares of Common Stock, (ii) Pre-Funded Warrants exercisable for an aggregate of 43,600 shares of Common Stock, at an exercise price of $0.002 per share, (iii) January/February Series A Warrants including Placement Agent Warrants to purchase up to a maximum of 1,651,544 shares of Common Stock, at an exercise price of $6.24 per share, subject to certain adjustments, and (iv) January/February Series B Warrants including Placement Agent Warrants to purchase up to a maximum of 422,797shares of Common Stock, at an exercise price of $0.002 per share,(v) 60,057 common stock warrants to Placement Agents subject to certain adjustments, for net proceeds of $1,250,000, after the deduction of fees and expenses payable to Aegis, and other offering expenses which includes a settlement with a former consultant, pursuant to which we issued to the former consultant $1,482,000 in value of securities of the Company consisting of (i) 50,000 shares of Common Stock and/or pre-funded warrants (ii) Series A Warrants to purchase up to an aggregate of 781,250 shares of Common Stock, at an exercise price of $6.24 per share, subject to certain adjustments, and (iii) Series B Warrants to